QIAGEN announces the launch of its new digital PCR (dPCR) Custom Assay Design Tool for copy number variation (CNV) analysis for use on its digital PCR platform QIAcuity, as well as several other enhancements in its GeneGlobe Design and Analysis Hub, a platform that integrates pre-designed assays with a database of more than 10,000 biological entities including genes, miRNAs, and pathways. The new advancements aim to support laboratories with a range of assay customization options, from simple to complex validated multiplex assays, while improving the user experience.